DROPERIDOL by Smith and Nephew is clinical pharmacology droperidol produces marked tranquilization and sedation. Approved for nausea, vomiting associated with surgical, diagnostic procedures. First approved in 1988.
Drug data last refreshed 20h ago
CLINICAL PHARMACOLOGY Droperidol produces marked tranquilization and sedation. It allays apprehension and provides a state of mental detachment and indifference while maintaining a state of reflex alertness. Droperidol produces an antiemetic effect as evidenced by the antagonism of apomorphine in…
Worked on DROPERIDOL at Smith and Nephew? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.